Publication|Articles|September 4, 2025
Supplements and Featured Publications
- CAR-T Cell Therapy: Navigating Access, Equity, and Operational Challenges
CAR-T Cell Therapy: Navigating Access, Equity, and Operational Challenges
Listen
0:00 / 0:00
Advertisement
This supplement was sponsored by Johnson & Johnson and Legend Biotech.
In this AJMC® Roundtable discussion, healthcare decision makers examined barriers to timely access to CAR-T cell therapy and identified solutions to streamline approval processes and enhance payer education for improved patient care.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Zanubrutinib Safe, Effective in Real-World CLL/SLL Cohort
2
Promises and Pitfalls of AI in Health Care
3
Paul Ryan Champions Health Care Policy Reform, AI Amid Government Shutdown
4
Review Outlines Shared Pathways Between CKD, VHD
5











































